Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Agilent Technologies (A)

Agilent Technologies (A)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Agilent Technologies Stock Underperforming the S&P 500?

Santa Clara, California-based Agilent Technologies, Inc. (A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets. It is valued at a market cap of $33 billion. 

Companies worth $10 billion or more are typically classified as “large-cap stocks,” and A fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the diagnostics & research industry. The company specializes in automating complex scientific workflows, integrating high-precision analytical tools such as gas and liquid chromatography with advanced AI-driven informatics to enhance laboratory throughput.

Fundamentals

See More
  • Market Capitalization, $K 32,962,696
  • Shares Outstanding, K 282,602
  • Annual Sales, $ 6,948 M
  • Annual Income, $ 1,303 M
  • EBIT $ 1,456 M
  • EBITDA $ 1,744 M
  • 60-Month Beta 1.31
  • Price/Sales 4.68
  • Price/Cash Flow 17.35
  • Price/Book 4.71

Options Overview Details

View History
  • Implied Volatility 31.23% (-3.85%)
  • Historical Volatility 24.65%
  • IV Percentile 47%
  • IV Rank 18.75%
  • IV High 59.03% on 04/10/25
  • IV Low 24.82% on 12/30/25
  • Expected Move (DTE 10) 4.93 (4.23%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 333
  • Volume Avg (30-Day) 2,060
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 26,463
  • Open Int (30-Day) 25,672
  • Expected Range 111.64 to 121.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate 1.41
  • Number of Estimates 6
  • High Estimate 1.42
  • Low Estimate 1.39
  • Prior Year 1.31
  • Growth Rate Est. (year over year) +7.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.32 +2.95%
on 03/09/26
129.56 -9.96%
on 02/11/26
-12.34 (-9.57%)
since 02/10/26
3-Month
113.32 +2.95%
on 03/09/26
150.10 -22.28%
on 01/13/26
-26.81 (-18.69%)
since 12/10/25
52-Week
96.43 +20.98%
on 04/09/25
160.27 -27.21%
on 11/25/25
-5.24 (-4.30%)
since 03/10/25

Most Recent Stories

More News
Is Agilent Technologies Stock Underperforming the S&P 500?

Although Agilent Technologies has underperformed the S&P 500 recently, analysts remain highly optimistic about the stock’s prospects.

A : 116.78 (+0.12%)
$SPX : 6,836.85 (+0.60%)
TMO : 504.70 (-1.03%)
Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

A : 116.78 (+0.12%)
$NASX : 22,881.64 (+0.82%)
IQV : 175.38 (-1.78%)
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 ...

A : 116.78 (+0.12%)
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky

1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky

PATH : 11.72 (-2.09%)
A : 116.78 (+0.12%)
ACN : 203.35 (-2.87%)
Agilent (NYSE:A) Reports Q4 CY2025 In Line With Expectations

Agilent (NYSE:A) Reports Q4 CY2025 In Line With Expectations

A : 116.78 (+0.12%)
Agilent: Fiscal Q1 Earnings Snapshot

Agilent: Fiscal Q1 Earnings Snapshot

A : 116.78 (+0.12%)
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Delivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS (3) guidance while confirming core - revenue growth ...

A : 116.78 (+0.12%)
How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks?

Danaher Corporation faces near-term relative weakness, but the Street’s conviction suggests recovery ahead.

A : 116.78 (+0.12%)
PINK : 35.10 (+0.26%)
MASI : 175.57 (+0.07%)
DHR : 198.48 (-0.16%)
What To Expect From Agilent’s (A) Q4 Earnings

What To Expect From Agilent’s (A) Q4 Earnings

A : 116.78 (+0.12%)
Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference

Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen’s 46 th...

A : 116.78 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments,...

See More

Key Turning Points

3rd Resistance Point 121.18
2nd Resistance Point 118.95
1st Resistance Point 117.79
Last Price 116.78
1st Support Level 114.40
2nd Support Level 112.17
3rd Support Level 111.01

See More

52-Week High 160.27
Fibonacci 61.8% 135.88
Fibonacci 50% 128.35
Fibonacci 38.2% 120.82
Last Price 116.78
52-Week Low 96.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar